(RTTNews) - Mainz Biomed N.V. (MYNZ), Thursday announced a collaboration with Quest Diagnostics Inc. (DGX) to commercialize the former's NextGen screening test for colorectal cancer, called ColoAlert ...
People are three times more likely to undergo at-home colon cancer screening if they're provided a free test, a new study says. About 30% of patients mailed a free stool test kit completed their ...